RHUMBLINE ADVISERS

Position in RCEL — AVITA Medical, Inc.

CIK 1115418 BOSTON, MA

Position in RCEL

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$98,586

+$2,563 QoQ

Shares Held

26,645

-4.3% QoQ

Ownership

0.087%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

16 quarters on record

Voting authority Sole 13% Shared 0% None 87%

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $1,402,735,897 across 83 Medical Devices names. RCEL ranks #70 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	2,876,810	$295,362,082
2	SYK	Stryker Corp	633,935	$208,304,701
3	MDT	Medtronic plc	2,241,292	$194,207,951
4	BSX	Boston Scientific Corp	2,674,641	$167,833,722
5	EW	Edwards Lifesciences Corp	1,067,753	$85,505,660
6	GEHC	GE HealthCare Technologies Inc.	763,138	$54,320,162
7	DXCM	Dexcom Inc	772,557	$48,516,579
8	STE	STERIS plc	214,808	$47,500,493

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$98,586	26,645	-4.3%	Shares	Sole	2026-05-12
2025-12-31	$96,023	27,833	-27.4%	Shares	Sole	2026-02-13
2025-09-30	$195,866	38,330	-9.1%	Shares	Sole	2025-11-06
2025-06-30	$223,068	42,168	+8.8%	Shares	Sole	2025-08-12
2025-03-31	$315,628	38,775	+9.8%	Shares	Sole	2025-05-29
2024-12-31	$452,185	35,327	+2.7%	Shares	Sole	2025-05-29
2024-09-30	$368,639	34,388	-5.9%	Shares	Sole	2024-11-12
2024-06-30	$289,317	36,530	+13.9%	Shares	Sole	2024-08-01
2024-03-31	$514,034	32,067	+3.4%	Shares	Sole	2024-05-09
2023-12-31	$425,649	31,024	-0.3%	Shares	Sole	2024-02-08
2023-09-30	$454,736	31,125	+15.2%	Shares	Sole	2023-11-09
2023-06-30	$459,763	27,029	+18.0%	Shares	Sole	2023-08-08
2022-03-31	$194,302	22,913	+23.3%	Shares	Sole	2022-05-12
2021-12-31	$222,672	18,587	-2.2%	Shares	Sole	2022-02-10
2021-09-30	$336,804	19,007	+6.1%	Shares	Sole	2021-11-12
2021-06-30	$367,533	17,911	—	Shares	Sole	2021-08-05
No filing history on record for this holder in this stock.